期刊文献+

成人外周血来源树突状细胞体外诱导培养动态监测 被引量:1

Culture of Dendritic Cells in Adult Peripheral Blood In Vitro
原文传递
导出
摘要 目的:分析体外诱导培养树突状细胞(dendritic cells,DCs)表面分子及成熟度的动态变化;方法:利用流式细胞仪(fluores-cence activated cell sorter,FACS)检测分析DCs表面成熟标志分子CD83和T细胞辅助分子CD58、CD54、CD40、CD80、CD86、HLA-DR、HLA-ABC表达水平;结果:体外诱导培养5 d细胞即高表达DCs标志分子CD11c,细胞成熟度与细胞表面T细胞辅助分子的表达水平随培养天数的增加有一定提高,但显著低于大肠杆菌LPS刺激的DCs;结论:诱导培养6 d DCs表型为CD83low、CD58low、CD54 low、CD40 low、CD80 low、CD86 low、HLA-DRhigh、HLA-ABChigh,为不成熟DCs。 Objective:To analyse the mature dynamic and phenotype molecular changes of human peripheral blood-derived den-dritic cells(DCs) in vitro;Methods:Monocytes,which were isolated from human peripheral blood mononuclear cells,were cultured in medium containing IL-4 and GM-CSF.After 5~6 days of culture to detects the mature marker CD83 and co-stimulatory molecules:CD58,CD54,CD80,CD86,CD40,HLA-DR,HLA-ABC,which was determined by fluorescence activated cell sorter(FACS);Results:After 5~6 days of culture,more than 95% of cells converted into iDCs with phenotype of CD11c+,CD54low,CD83low,CD40low,CD58low,CD86low,and CD80low,which was determined by fluorescence activated cell sorter(FACS).E.coli LPS-pulsed DCs exhibit-ed significantly high expression of mature marker CD83 and co-stimulatory molecules:CD58,CD54,CD80,CD86,CD40.Conclusions:These results suggest that human monocyte-derived DCs are immature after 5~6 days of culture.
机构地区 解放军 解放军
出处 《现代生物医学进展》 CAS 2010年第23期4500-4503,共4页 Progress in Modern Biomedicine
关键词 树突状细胞 流式细胞分析 成熟标志分子 T细胞辅助分子 dendritic cells FACS mature marker co-stimulatory molecules
  • 相关文献

参考文献8

  • 1Gogolak P, Rethi B, Hajas G, et al. Targeting dendritic cells for priming cellular immune responses [J]. J Mol Recognit, 2003, 16 (5): 299-317.
  • 2Banchereau J, Steinman RM. Dendritic cells and the control of immunity[J].Nature, 1998, 392(6673):245-52.
  • 3Steinman RM, Banchereau J. Taking dendritic cells into medicine [J]. Nature, 2007, 449(7161):419-26.
  • 4Rescigno M, Martino M, Sutherland CL, et al. Dendritic cell survival and maturation are regulated by different signaling pathways[J]. J Exp Med, 1998, 188(11):2175-80.
  • 5Dallal RM, Lotze MT. The dendritic cell and human cancer vaccines [J]. Curr Opin Immunol, 2000, 12(5):583-8.
  • 6Banchereau J, Schuler TB, Palucka AK, et al. Dendritic cells as vectors for therapy[J]. Cell, 2001, 106(3):271-4.
  • 7Gogolak PB, Rethi G, Hajas, et al. Targeting dendritic cells for priming cellular immune responses [J]. J Mol Recognit, 2003, 16 (5): 299-317.
  • 8Prazma CM,Yazawa N, Fujimoto Y, et al. CD83 expression is a sensitive marker of activation required for B cell and CD4- T cell longevity in vivo[J]. J Immunol, 2007, 179(7):4550-62.

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部